Does Sacubitril And Valsartan Interact with Spironolactone?
CDI records a major classification for Sacubitril And Valsartan and Spironolactone. The stored summary is: May lead to increased serum potassium levels. Monitor potassium levels during concomitant use. The mechanism involves both block angiotensin ii or its effects, increasing serum potassium. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Sacubitril And Valsartan Class
- Angiotensin 2 Receptor Blocker
- Spironolactone Class
- Aldosterone Antagonist
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Both block angiotensin II or its effects, increasing serum potassium
What To Tell Your Doctor or Pharmacist
If you are taking Sacubitril And Valsartan and your doctor is considering prescribing Spironolactone (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider